Frank A. Wilson
Mr. Wilson was Chief Financial Officer and Senior Vice President of PerkinElmer, Inc., a life sciences diagnostics, discovery and analytical solutions company, from 2009 until his retirement in 2018. Prior to joining PerkinElmer, he held key business development and finance roles over 12 years at the Danaher Corporation, the life sciences and industrial conglomerate, including Corporate Vice President of Investor Relations. Previously, Mr. Wilson worked for several years at AlliedSignal, Inc., now Honeywell International Inc., where he served as Vice President of Finance and Chief Financial Officer for Commercial Aviations Systems. His earlier experience included financial and controllership positions of increasing responsibility at PepsiCo Inc., as well as roles at E.F. Hutton and Company, and KPMG Peat Marwick. Mr. Wilson is a member of the Board of Directors of Alkermes, a fully integrated, global biopharmaceutical company and is a member of the Board of Directors of Novanta, a global supplier to medical and advanced industrial OEMS of core components and subsystems that deliver extreme precision and performance. He is also a Senior Advisor for Astor Place Holdings, the private investment arm of Select Equity Group L.P. Mr. Wilson previously served as member of the Board of Directors and Chair of the Audit Committee of Sparton Corporation, a provider of complex and sophisticated electromechanical devices, which was acquired by Cerberus. He is a Certified Public Accountant.